FAVORABLE PROGNOSIS IN METASTATIC ADRENAL CARCINOMA: AN UNEXPECTED OUTCOME

Aisha Sheikh; Imran Hassan

doi:10.47391/JPMA.3494

Back

FAVORABLE PROGNOSIS IN METASTATIC ADRENAL CARCINOMA: AN UNEXPECTED OUTCOME

Journal article

Open access

Peer reviewed

FAVORABLE PROGNOSIS IN METASTATIC ADRENAL CARCINOMA: AN UNEXPECTED OUTCOME

Aisha Sheikh and Imran Hassan

Endocrine practice, Vol.25, pp.23-23

04/01/2019

DOI: 10.47391/JPMA.3494

Files and links (1)

url

https://doi.org/10.47391/JPMA.3494View

Published (Version of record) Open Access

Abstract

The case of a 45-year-old male patient diagnosed with European Network for the Study of Adrenal Tumours (ENSAT) criteria, stage IV adrenocortical carcinoma (ACC) with unexpectedly prolonged survival is being reported. The patient underwent resection of stage IV ACC and despite suboptimal adherence to postoperative mitotane and chemotherapy, had a prolonged survival spanning almost seven years. The possible reasons for such an outcome are discussed. ACC is a rare tumour with stage 4 disease known to be associated with a particularly grim prognosis. A low grade on histology (mitotic index 11-12 per 50 HPF) was likely responsible for the prolonged survival of our patient. Low grade disease may predict extended survival in stage IV ACC.

Chemotherapy

Metastasis

Tumors

Medical prognosis

Details

Title: Subtitle: FAVORABLE PROGNOSIS IN METASTATIC ADRENAL CARCINOMA: AN UNEXPECTED OUTCOME
Creators: Aisha Sheikh
Imran Hassan
Resource Type: Journal article
Publication Details: Endocrine practice, Vol.25, pp.23-23
DOI: 10.47391/JPMA.3494
ISSN: 1530-891X
eISSN: 1934-2403
Publisher: Elsevier Limited
Language: English
Date published: 04/01/2019
Academic Unit: Surgery
Record Identifier: 9984322773402771

Metrics

14 Record Views